GCVRX
Price
$23.63
Change
+$0.14 (+0.60%)
Updated
Jan 17 closing price
Net Assets
531.69M
RMFCX
Price
$55.77
Change
+$0.30 (+0.54%)
Updated
Jan 17 closing price
Net Assets
103.41B
Ad is loading...

GCVRX vs RMFCX

Header iconGCVRX vs RMFCX Comparison
Open Charts GCVRX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts R
Price$23.63
Change+$0.14 (+0.60%)
VolumeN/A
Net Assets531.69M
American Funds American Mutual R3
Price$55.77
Change+$0.30 (+0.54%)
VolumeN/A
Net Assets103.41B
GCVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCVRX vs. RMFCX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCVRX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 103B vs. GCVRX (532M). RMFCX pays higher dividends than GCVRX: RMFCX (1.69) vs GCVRX (0.82). GCVRX was incepted earlier than RMFCX: GCVRX (17 years) vs RMFCX (23 years). GCVRX is a more actively managed with annual turnover of: 208.00 vs. RMFCX (25.00). GCVRX has a lower initial minimum investment than RMFCX: GCVRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.43 vs. GCVRX (7.62). RMFCX return over 5 years is better than : 37.82 vs. GCVRX (9.02).
GCVRXRMFCXGCVRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years23 years-
Gain YTD2.9182.162135%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets532M103B1%
Annual Yield % from dividends0.821.6948%
Returns for 1 year7.6212.4361%
Returns for 3 years3.4412.6027%
Returns for 5 years9.0237.8224%
Returns for 10 years50.9665.1878%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDZI5.160.23
+4.77%
CADIZ
HOOD48.152.07
+4.49%
Robinhood Markets
NERV2.230.08
+3.72%
Minerva Neurosciences
WHD63.63-0.15
-0.24%
Cactus
EOLS10.51-0.10
-0.94%
Evolus